HEMADY (nda211379)- (20MG)

Generic Name	DEXAMETHASONE	Innovator	DEXCEL
Dosage	20MG
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	2037-Dec-18	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	HEMADY is a corticosteroid indicated in combination with other antimyeloma products for the treatment of adults with multiple myeloma.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	2

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
20MG	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of HEMADY